Cargando…
Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-κB and Nrf2 Signaling Pathways
Saccharomyces boulardii (S. boulardii) is a probiotic yeast that is widely used to treat gastrointestinal disorders. The present study is aimed to explore the therapeutic effects of S. boulardii on dextran sulfate sodium- (DSS-) induced murine ulcerative colitis (UC) and illustrate the mechanisms of...
Autores principales: | Gao, Hui, Li, Yinzheng, Sun, Jie, Xu, Huzi, Wang, Meng, Zuo, Xuezhi, Fu, Qiang, Guo, Yanchao, Chen, Zhenyan, Zhang, Piwei, Li, Xudong, Wang, Niwen, Ye, Ting, Yao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342159/ https://www.ncbi.nlm.nih.gov/pubmed/34367460 http://dx.doi.org/10.1155/2021/1622375 |
Ejemplares similares
-
Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile
por: Gao, Hui, et al.
Publicado: (2023) -
Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice
por: Dong, Jin-Pei, et al.
Publicado: (2019) -
Both Saccharomyces boulardii and Its Postbiotics Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, Association with Modulating Inflammation and Intestinal Microbiota
por: Xu, Xinge, et al.
Publicado: (2023) -
Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
por: Zhou, Huan, et al.
Publicado: (2018) -
Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota
por: Wang, Chunsaier, et al.
Publicado: (2019)